Abstract
A Safety Study of 2 Formulations of GlaxoSmithKline Biologicals' (GSK's) Human Rotavirus (HRV) Vaccine in Healthy Infants of Age 6-12 Weeks
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have